Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
March 08, 2021 at 07:59 am EST
Share
Guanhao Biotech Co.,Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 436.957 million compared to CNY 437.886 million a year ago. Operating income was CNY 44.963 million compared to operating loss of CNY 486.857 million a year ago. Net income was CNY 46.594 million compared to net loss of CNY 465.329 million a year ago. Basic earnings per share from continuing operations was CNY 0.18 compared to basic loss per share from continuing operations of CNY 1.75 a year ago.
Guanhao Biotech Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of regeneration medical materials and medical implanted devices. The Company primarily provides biological dura mater patches, chest general surgery department patching membranes (type P) and (type B), asepsis biological wound-surface protection membranes, type B dura matrix, intraocular lens as well as agent products. The Company is also engaged in provision of related technological services.
GUANHAO BIOTECH CO.,LTD. 
